Last reviewed · How we verify

Cryopreserved platelets

Australian and New Zealand Intensive Care Research Centre · Phase 3 active Biologic

Cryopreserved platelets are platelets that have been frozen and stored for extended periods, then thawed for transfusion to restore hemostatic function in patients with thrombocytopenia or platelet dysfunction.

Cryopreserved platelets are platelets that have been frozen and stored for extended periods, then thawed for transfusion to restore hemostatic function in patients with thrombocytopenia or platelet dysfunction. Used for Thrombocytopenia in critically ill patients requiring platelet transfusion, Perioperative bleeding management in patients with platelet dysfunction or deficiency.

At a glance

Generic nameCryopreserved platelets
SponsorAustralian and New Zealand Intensive Care Research Centre
Drug classBlood product / Cellular therapy
ModalityBiologic
Therapeutic areaHematology / Critical Care
PhasePhase 3

Mechanism of action

Cryopreservation uses cryoprotectants and controlled freezing to maintain platelet viability during long-term storage at ultra-low temperatures, extending shelf life beyond the standard 5-day room-temperature storage. Upon thawing and transfusion, these platelets restore platelet count and function to support hemostasis in critically ill or bleeding patients. This approach addresses the logistical challenges of platelet inventory management and availability in emergency and intensive care settings.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results